Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

Por Gori, S, Colozza, M, Mosconi, A M, Franceschi, E, Basurto, C, Cherubini, R, Sidoni, A, Rulli, A, Bisacci, C, Angelis, V De, Crinò, L, Tonato, M
Publicado em 2004